Gibson Christopher
Former Director at RXRX
- Sold, on record
- $39.4M
- Dollars the filings state
- Form 4 sales
- 75
- Latest Jun 5, 2026
- Form 144 notices
- 93
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- RXRXRECURSION PHARMACEUTICALS, INC.Former Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice RXRXNoticeAug 7, 2026 2026
Filed to sell 100,000 shares ($325k)
Gibson Christopher, Former Director
No 10b5-1 plan2.5x usual sizeFiling
- 2 Form 144 notice RXRXNoticeAug 10, 2026 +3 days
Filed to sell 100,000 shares ($327k)
Gibson Christopher, Former Director
No 10b5-1 plan2.5x usual sizeFiling
- 3 Form 144 notice RXRXNoticeAug 12, 2026 +2 days
Filed to sell 50,000 shares ($169k)
Gibson Christopher, Former Director
No 10b5-1 plan1.3x usual sizeFiling
- 4 Form 144 notice RXRXNoticeAug 13, 2026 +1 day
Filed to sell 100,000 shares ($331k)
Gibson Christopher, Former Director
No 10b5-1 plan2.5x usual sizeFiling
- 5 Form 144 notice RXRXNoticeAug 18, 2026 +5 days
Filed to sell 26,806 shares ($80k)
Gibson Christopher, Former Director
No 10b5-1 plan0.7x usual sizeFiling
- 6 Form 144 notice RXRXNoticeAug 19, 2026 +1 day
Filed to sell 100,000 shares ($328k)
Gibson Christopher, Former Director
No 10b5-1 plan2.5x usual sizeFiling
- 7 Form 144 notice RXRXNoticeAug 20, 2026 +1 day
Filed to sell 75,000 shares ($255k)
Gibson Christopher, Former Director
No 10b5-1 plan1.9x usual sizeFiling
- 8 Form 144 notice RXRXNoticeAug 21, 2026 +1 day
Filed to sell 77,290 shares ($262k)
Gibson Christopher, Former Director
No 10b5-1 plan1.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (168)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Aug 21, 2026 | RXRX | Former Director | Form 144 notice | 77,290 | $262k | Notice | SEC | |
| Aug 20, 2026 | Aug 20, 2026 | RXRX | Former Director | Form 144 notice | 75,000 | $255k | Notice | SEC | |
| Aug 19, 2026 | Aug 19, 2026 | RXRX | Former Director | Form 144 notice | 100,000 | $328k | Notice | SEC | |
| Aug 18, 2026 | Aug 18, 2026 | RXRX | Former Director | Form 144 notice | 26,806 | $80k | Notice | SEC | |
| Aug 13, 2026 | Aug 13, 2026 | RXRX | Former Director | Form 144 notice | 100,000 | $331k | Notice | SEC | |
| Aug 12, 2026 | Aug 12, 2026 | RXRX | Former Director | Form 144 notice | 50,000 | $169k | Notice | SEC | |
| Aug 10, 2026 | Aug 10, 2026 | RXRX | Former Director | Form 144 notice | 100,000 | $327k | Notice | SEC | |
| Aug 7, 2026 | Aug 7, 2026 | RXRX | Former Director | Form 144 notice | 100,000 | $325k | Notice | SEC | |
| Aug 4, 2026 | Aug 4, 2026 | RXRX | Former Director | Form 144 notice | 75,000 | $245k | Notice | SEC | |
| Jul 30, 2026 | Jul 30, 2026 | RXRX | Former Director | Form 144 notice | 75,000 | $225k | Notice | SEC | |
| Jul 29, 2026 | Jul 29, 2026 | RXRX | Former Director | Form 144 notice | 50,000 | $151k | Notice | SEC | |
| Jul 27, 2026 | Jul 27, 2026 | RXRX | Former Director | Form 144 notice | 50,000 | $153k | Notice | SEC | |
| Jul 21, 2026 | Jul 21, 2026 | RXRX | Former Director | Form 144 notice | 100,000 | $304k | Notice | SEC | |
| Jul 20, 2026 | Jul 20, 2026 | RXRX | Former Director | Form 144 notice | 100,000 | $290k | Notice | SEC | |
| Jul 17, 2026 | Jul 17, 2026 | RXRX | Former Director | Form 144 notice | 100,000 | $297k | Notice | SEC | |
| Jul 16, 2026 | Jul 16, 2026 | RXRX | Former Director | Form 144 notice | 100,000 | $311k | Notice | SEC | |
| Jul 15, 2026 | Jul 15, 2026 | RXRX | Former Director | Form 144 notice | 123,334 | $410k | Notice | SEC | |
| Jul 14, 2026 | Jul 14, 2026 | RXRX | Former Director | Form 144 notice | 100,000 | $330k | Notice | SEC | |
| Jul 13, 2026 | Jul 13, 2026 | RXRX | Former Director | Form 144 notice | 100,000 | $343k | Notice | SEC | |
| Jul 10, 2026 | Jul 10, 2026 | RXRX | Former Director | Form 144 notice | 100,000 | $354k | Notice | SEC | |
| Jul 9, 2026 | Jul 9, 2026 | RXRX | Former Director | Form 144 notice | 286,000 | $1.1M | Notice | SEC | |
| Jul 8, 2026 | Jul 8, 2026 | RXRX | Former Director | Form 144 notice | 200,000 | $738k | Notice | SEC | |
| Jul 7, 2026 | Jul 7, 2026 | RXRX | Former Director | Form 144 notice | 250,000 | $988k | Notice | SEC | |
| Jul 6, 2026 | Jul 6, 2026 | RXRX | Former Director | Form 144 notice | 100,000 | $378k | Notice | SEC | |
| Jul 2, 2026 | Jul 2, 2026 | RXRX | Former Director | Form 144 notice | 100,000 | $375k | Notice | SEC | |
| Jul 1, 2026 | Jul 1, 2026 | RXRX | Former Director | Form 144 notice | 100,000 | $367k | Notice | SEC | |
| Jun 18, 2026 | Jun 18, 2026 | RXRX | Director | Form 144 notice | 300,440 | $962k | Notice | SEC | |
| Jun 18, 2026 | Jun 18, 2026 | RXRX | Director | Form 144 notice | 40,000 | $127k | Notice | SEC | |
| Jun 5, 2026 | Jun 5, 2026 | RXRX | Director | Form 4 sale | 40,000 | $145k | 4.3% | Routine | SEC |
| Jun 5, 2026 | Jun 5, 2026 | RXRX | Director | Form 144 notice | 40,000 | $145k | Notice | SEC | |
| May 22, 2026 | May 27, 2026 | RXRX | Director | Form 4 sale | 40,000 | $123k | 4.3% | Routine | SEC |
| May 22, 2026 | May 22, 2026 | RXRX | Director | Form 144 notice | 40,000 | $123k | Notice | SEC | |
| May 7, 2026 | May 8, 2026 | RXRX | Director | Form 4 sale | 40,000 | $135k | 4.1% | Routine | SEC |
| May 7, 2026 | May 7, 2026 | RXRX | Director | Form 144 notice | 40,000 | $135k | Notice | SEC | |
| Apr 22, 2026 | Apr 24, 2026 | RXRX | Director | Form 4 sale | 40,000 | $144k | 4.2% | Routine | SEC |
| Apr 22, 2026 | Apr 22, 2026 | RXRX | Director | Form 144 notice | 40,000 | $144k | Notice | SEC | |
| Apr 7, 2026 | Apr 8, 2026 | RXRX | Director | Form 4 sale | 40,000 | $124k | 4.2% | Routine | SEC |
| Apr 7, 2026 | Apr 7, 2026 | RXRX | Director | Form 144 notice | 40,000 | $124k | Notice | SEC | |
| Mar 23, 2026 | Mar 25, 2026 | RXRX | Director | Form 4 sale | 40,000 | $130k | 4.2% | Routine | SEC |
| Mar 23, 2026 | Mar 23, 2026 | RXRX | Director | Form 144 notice | 40,000 | $130k | Notice | SEC | |
| Feb 19, 2026 | Feb 19, 2026 | RXRX | Director | Form 4 sale | 40,000 | $138k | 4.2% | Routine | SEC |
| Feb 19, 2026 | Feb 19, 2026 | RXRX | Director | Form 144 notice | 40,000 | $138k | Notice | SEC | |
| Feb 4, 2026 | Feb 6, 2026 | RXRX | Director | Form 4 sale | 40,000 | $165k | 4.2% | Routine | SEC |
| Feb 4, 2026 | Feb 4, 2026 | RXRX | Director | Form 144 notice | 40,000 | $165k | Notice | SEC | |
| Jan 20, 2026 | Jan 22, 2026 | RXRX | Director | Form 4 sale | 40,000 | $179k | 4.2% | Routine | SEC |
| Jan 20, 2026 | Jan 20, 2026 | RXRX | Director | Form 144 notice | 40,000 | $179k | Notice | SEC | |
| Jan 5, 2026 | Jan 7, 2026 | RXRX | Director | Form 4 sale | 40,000 | $170k | 4.1% | Routine | SEC |
| Jan 5, 2026 | Jan 5, 2026 | RXRX | Director | Form 144 notice | 40,000 | $170k | Notice | SEC | |
| Dec 19, 2025 | Dec 19, 2025 | RXRX | Chief Executive Officer | Form 4 sale | 40,000 | $180k | 4.2% | Routine | SEC |
| Dec 19, 2025 | Dec 19, 2025 | RXRX | Officer, Director | Form 144 notice | 40,000 | $180k | Notice | SEC |